SAVALE Laurent
Le Kremlin-Bicêtre, 94270, France
NCT Number: NCT03926572
The main objective of this study is to analyze the survival of a cohort of patients admitted for acute decompensation of pulmonary arterial hypertension or postembolic pulmonary hypertension and to establish the prognostic value of biomarkers.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Le Kremlin-Bicêtre, 94270, France
It is planned to include 150 patients over a two-year period. The primary endpoint is a composite endpoint including death, circulatory assistance or emergency transplantation within 90 days following admission to intensive care unit. Patients will be treated according to the usual practice. A biobank will be created from blood samples taken at admission, days 3 and days 7. Prognostic value of pre-selected biomarkers will be analyzed and a proteomic analysis will be performed in order to identify new biomarkers. The prognostic value of these new biological parameters will be compared to the usual monitoring parameters that will be collected during follow-up (clinical, echocardiographic and haemodynamic parameters). In a second step, it will establish, using a dynamic model, the best combinations of parameters allowing to best assessment of prognosis of patients suffering from PH and hospitalized for acute right ventricular failure.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A biobank will be created from the blood samples taken on admission, days 3 and 7 of admission. The prognostic value of the preselected biomarkers will be analyzed and a proteomic analysis will be performed to identify new biomarkers. The prognostic value of these new biological parameters will be compared to the usual surveillance parameters that will be collected during the follow-up (clinical, echocardiographic and hemodynamic parameters)
Time frame: 90 days
The primary endpoint is a composite endpoint including death, circulatory assistance or emergency transplantation within 90 days following admission to intensive care unit
Time frame: 1 month
Survival without transplantation or circulatory assitance at 1 month
Time frame: 12 months
Survival ithout transplantation or circulatory assitance at 12 month
Assistance Publique - Hôpitaux de Paris
Other
Pronostic Study of Biomarkers in Acute Decompensation of Pulmonary Hypertension
Acronym: PROPULS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03626688
Cardiovascular Diseases, Connective Tissue Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT01273259
Cardiovascular Diseases, Chronic Disease
Bordeaux, France
View Trial DetailsNCT00581087
Cardiovascular Diseases, Chronic Disease
Bordeaux, France
View Trial DetailsNCT00595049
Cardiovascular Diseases, Connective Tissue Diseases
Camperdown, Australia
View Trial Details